Antiaging Quantum Living Inc.
AAQL
$0.60
-$0.10-13.74%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.03M | 1.31M | 1.12M | 907.30K | 818.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.03M | 1.31M | 1.12M | 907.30K | 818.00K |
| Cost of Revenue | 332.30K | 628.50K | 497.30K | 446.00K | 389.50K |
| Gross Profit | 702.10K | 681.60K | 627.00K | 461.30K | 428.50K |
| SG&A Expenses | 1.54M | 1.32M | 1.19M | 1.18M | 1.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.87M | 1.95M | 1.69M | 1.62M | 1.61M |
| Operating Income | -835.30K | -641.00K | -567.60K | -714.20K | -789.90K |
| Income Before Tax | -821.00K | -630.30K | -487.40K | -633.90K | -720.40K |
| Income Tax Expenses | 16.70K | 16.50K | 16.40K | 6.00K | -- |
| Earnings from Continuing Operations | -0.84 | -0.65 | -0.50 | -0.64 | -0.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -837.70K | -646.80K | -503.80K | -639.90K | -720.40K |
| EBIT | -835.30K | -641.00K | -567.60K | -714.20K | -789.90K |
| EBITDA | -700.50K | -481.30K | -415.60K | -554.70K | -645.80K |
| EPS Basic | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.03 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 125.93M | 121.70M | 119.98M | 119.94M | 119.94M |
| Average Diluted Shares Outstanding | 125.93M | 121.70M | 119.98M | 119.94M | 119.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |